Overview
October 5th delivered 22 continuation breakout signals despite a Bearish SA Regime reading, a notable divergence that warrants caution. Breadth sits at just 23.9% above the 40-day SMA, yet sentiment remains bullish on both counts — a mismatch that suggests this breadth measure, not sentiment, should drive position sizing today. The sector leadership board tells the real story: Technology (2.6% ATR%) and Health Care (1.6% ATR%) are the only groups with genuine momentum, while Industrials, Utilities, and Real Estate are bleeding (-2.1% to -4.1%). Our signal list mirrors this split almost perfectly — Medical/Health Care and Software/Technology names dominate the quality setups, while Building, Machinery, and Electronics names lag in relative strength.
Quality Score: 3/5. Per the bearish-regime adjustment, we’re capping conviction here — signal count and institutional depth are excellent, but broad market headwinds limit the odds of follow-through on names outside the leading sectors. This is a day to be selective, favoring Health Care and Software names near demand with strong institutional support, not a day to chase every green candle.
Sector Concentration: Medical (WAT, IDXX, TMO, BIIB) and Software (SHOP, TEAM, NET) account for 7 of the 10 top candidates — a clear thematic tilt toward the regime’s leading sectors, with Building, Machinery, and Electronics representing weaker, regime-lagging outliers.
Top 5 Picks
WAT ($440.12) — Medical / Medical-Systems
Waters is pushing a 3.5% gain on 1.4x RVOL with a healthy 2.5% ATR%-M reading, sitting just 1.8% off its 52-week high. Trading “between” zones with daily demand at 400.90-407.24 (7.5% below), this is a momentum continuation play riding sector tailwinds in Health Care, backed by deep institutional sponsorship (2,526 funds, B1 bucket).
| Level | Price |
|---|---|
| Entry | $440.12 |
| Stop | $428.68 |
| Target | $463.00 |
Institutional Backing: 2,526 funds, Bucket B1 — one of the strongest institutional footprints on today’s list.
SHOP ($160.11) — Software / Comp Sftwr-Enterprise
Shopify’s 5.8% surge is the day’s largest single move, with demand (150.28-151.77) and supply (167.44-170.90) both clearly mapped — a textbook “between zones” continuation setup. ATR%-M of 3.1% confirms expanding volatility in the right direction, and the stock remains 12.1% off highs, leaving room to run.
| Level | Price |
|---|---|
| Entry | $160.11 |
| Stop | $152.43 |
| Target | $175.48 |
Institutional Backing: 3,108 funds, Bucket B2 — the deepest institutional base among today’s Software names.
NET ($359.49) — Software / Comp Sftwr-Enterprise
Cloudflare is breaking at_demand (344.51-351.80, strength 6.4) with supply compressing tightly just 0.26% away (360.43-363.85), signaling a coiled setup. A 3.0% move on 3.6% ATR%-M shows real conviction, and the tight supply overhang means a clean breakout above $364 could accelerate quickly.
| Level | Price |
|---|---|
| Entry | $359.49 |
| Stop | $340.80 |
| Target | $397.08 |
Institutional Backing: 2,237 funds — solid sponsorship supporting the demand-zone bounce.
TMO ($676.76) — Medical / Medical-Research
Thermo Fisher’s 3.4% breakout comes with the strongest institutional footprint on today’s list and a 3.8% ATR%-M reading, the highest volatility expansion among our Medical names. Daily demand sits at 648.29-654.80 (6.8 strength), just 3.2% below current price, providing a logical reference for risk management.
| Level | Price |
|---|---|
| Entry | $676.76 |
| Stop | $660.51 |
| Target | $709.19 |
Institutional Backing: 4,794 funds — the single deepest institutional base of the entire signal list.
BIIB ($223.59) — Medical / Profitable Biotech
Biogen is breaking at_demand on the 4-hour chart (219.05-220.86), with supply mapped tightly at 226.40-231.27. A modest 1.7% move on 1.5% ATR%-M is lower-velocity than other picks, but the tight zone structure and strong institutional base make this a lower-risk continuation entry within a leading sector.
| Level | Price |
|---|---|
| Entry | $223.59 |
| Stop | $218.00 |
| Target | $234.77 |
Institutional Backing: 2,458 funds — strong support for a biotech name trading near multi-timeframe demand.
Honorable Mentions
- TEAM ($196.65) — Strong 4.7% move and 4.0% ATR%-M, but demand zone is 14% away on the 1h chart, making risk management less precise.
- XMTR ($107.70) — 5.0% gain near 52-week highs with solid demand support at 96.84-99.53, though institutional data is unavailable (N/A bucket).
- IDXX ($527.07) — At_demand setup with tight supply overhead (534.41-536.35), but negative ATR%-M (-1.2%) signals fading momentum.
- TT ($470.76) — At_demand bounce candidate, but Building sector is a regime laggard (-2.1% ATR% Industrials-adjacent).
- MTD ($1,541.63) — Sitting at_supply (0.08% away) makes this the riskiest setup on the list; avoid chasing into resistance.
Strategy Summary
Today’s 22 signals present above-average opportunity, but the Bearish SA Regime demands discipline — we’ve capped quality at 3/5 and concentrated picks in Health Care and Software, the only two sectors showing genuine ATR% leadership. Institutional backing across our Top 5 is exceptional (2,200-4,800+ funds each), which should help buffer broader market volatility. Risk/reward skews favorably on NET and BIIB given their tight demand-zone proximity, while WAT, SHOP, and TMO offer higher-velocity moves for traders comfortable with wider stops. Avoid Building, Machinery, and at-supply setups like MTD until regime conditions improve.